 |
|
Personalized treatment of hepatitis B
Anna S. Lok
Clin Mol Hepatol. 2015;21(1):1-6. Published online 2015 Mar 25 DOI: https://doi.org/10.3350/cmh.2015.21.1.1
|
|
Citations to this article as recorded by
 Position statement on the use of Tenofovir Alafenamide for the treatment of chronic Hepatitis B Virus infection in Africa
Edward John Gane, Allah Kouadio Emile, Onyekwere Charles Asabamaka, Mongo Onkouo, Oudou Njoya, Okon Anassi Jean Baptiste, SOMDA Küssome Paulin, Sombie Arsene Roger, Tadesse T Mekonen
Gastroenterology & Hepatology: Open Access.2021; 11(2): 57. CrossRef An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia
Michael R. Charlton, Altaf Alam, Akash Shukla, Bekhbold Dashtseren, Cosmas Rinaldi Adithya Lesmana, Davadoorj Duger, Diana Alcantara Payawal, Do Duy Cuong, Ganbolor Jargalsaikhan, Ian Homer Yee Cua, Jose Decena Sollano, Karam Romeo Singh, Kaushal Madan, K
Journal of Gastroenterology.2020; 55(9): 811. CrossRef ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens
Katherine E. Squires, Douglas L. Mayers, Gregory R. Bluemling, Alexander A. Kolykhalov, David B. Guthrie, Prabhakar Reddy, Debbie G. Mitchell, Manohar T. Saindane, Zachary M. Sticher, Vindhya Edpuganti, Abel De La Rosa
Antimicrobial Agents and Chemotherapy.2020;[Epub] CrossRef Mathematical modeling of hepatitis B virus infection for antiviral therapy using LHAM
M. Aniji, N. Kavitha, S. Balamuralitharan
Advances in Difference Equations.2020;[Epub] CrossRef The risk of hepatocellular carcinoma among chronic hepatitis B virus‐infected patients outside current treatment criteria
Dong Hyun Sinn, Sung Eun Kim, Beom Kyung Kim, Ji Hoon Kim, Moon Seok Choi
Journal of Viral Hepatitis.2019; 26(12): 1465. CrossRef Development and validation of an LC–MS/MS method for quantification of NC-8 in rat plasma and its application to pharmacokinetic studies
Baxter Hepburn Kachingwe, Yow-Shieng Uang, Tsurng-Juhn Huang, Li-Hsuan Wang, Shwu-Jiuan Lin
Journal of Food and Drug Analysis.2018; 26(1): 401. CrossRef Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5′-UTR of TRIM22
Keo-Heun Lim, Eun-Sook Park, Doo Hyun Kim, Kyung Cho Cho, Kwang Pyo Kim, Yong Kwang Park, Sung Hyun Ahn, Seung Hwa Park, Kee-Hwan Kim, Chang Wook Kim, Hong Seok Kang, Ah Ram Lee, Soree Park, Heewoo Sim, Juhee Won, Kieun Seok, Jueng Soo You, Jeong-Hoon Lee
Gut.2018; 67(1): 166. CrossRef Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial
H. J. Yim, I. H. Kim, S. J. Suh, Y. K. Jung, J. H. Kim, Y. S. Seo, J. E. Yeon, C. W. Kim, S. Y. Kwon, S. H. Park, M. S. Lee, S. H. Um, K. S. Byun
Journal of Viral Hepatitis.2018; 25(11): 1321. CrossRef Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy
Mi Na Kim, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Kwang-Hyub Han
Journal of Medical Virology.2017; 89(1): 85. CrossRef Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir
Mi Na Kim, Seong Gyu Hwang, Kyu Sung Rim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Liver International.2017; 37(12): 1788. CrossRef Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kijun Song, Kwang-Hyub Han
Medicine.2016; 95(20): e3434. CrossRef Multidrug resistance protein 4 is a critical protein associated with the antiviral efficacy of nucleos(t)ide analogues
Wei Liu, Hongxuan Song, Qian Chen, Chunli Xu, Wenjing Zhang, Yutian Liu, Baoju Wang, Dongping Xu, Mengji Lu, Dongliang Yang, Xin Zheng
Liver International.2016; 36(9): 1284. CrossRef Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn
Clinical Gastroenterology and Hepatology.2016; 14(11): 1647. CrossRef Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay
Atsuya Yamashita, Yuusuke Fujimoto, Mayumi Tamaki, Andi Setiawan, Tomohisa Tanaka, Kaori Okuyama-Dobashi, Hirotake Kasai, Koichi Watashi, Takaji Wakita, Masaaki Toyama, Masanori Baba, Nicole de Voogd, Shinya Maekawa, Nobuyuki Enomoto, Junichi Tanaka, Kohj
Marine Drugs.2015; 13(11): 6759. CrossRef Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics
Hisashi Narimatsu
Expert Review of Proteomics.2015; 12(6): 683. CrossRef Emerging Challenges in Managing Hepatitis B in HIV Patients
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José M. Peña, José V. Fernández-Montero, Laura Benítez, Isabella Esposito, Pablo Barreiro
Current HIV/AIDS Reports.2015; 12(3): 344. CrossRef Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol
Lei Wang
World Journal of Gastroenterology.2015; 21(32): 9544. CrossRef
|